Pipeline
Critical Pharmaceuticals are experts in drug delivery and are developing a number of ground breaking products to treat diseases as diverse as growth hormone deficiency and schizophrenia. Critical Pharmaceuticals lead product is CP024, a nasal formulation of human growth hormone (hGH), that uses our CriticalSorb technology and has shown comparable bioactivity to a subcutaneous injection in an ongoing Phase 1 clinical development program. CP016 is Critical Pharmaceuticals long acting growth hormone product that has completed preclinical development.
See our Pipeline 
Partnering
Critical Pharmaceuticals actively partners its drug delivery technologies and candidate drugs with pharmaceutical and biotechnology companies. For more information, or to discuss a specific opportunity, please contact us.
Contact Us
|
